Global Low-Concentration Atropine Market 2024-2028
The low-concentration atropine market is forecasted to grow by USD 1,039.97 mn during 2023-2028, accelerating at a CAGR of 18.81% during the forecast period. The report on the low-concentration atropine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of myopia, rising awareness regarding vision care, and growing demand for vision correction among aging population.
Technavio's low-concentration atropine market is segmented as below:
By Type
Atropine sulfate 0.01 percentage
Atropine sulfate 0.025 percentage
Atropine sulfate 0.05 percentage
By Application
Child
Adult
By Geography
Asia
North America
Europe
Rest of World (ROW)
This study identifies the growing number of clinical trials by market vendors as one of the prime reasons driving the low-concentration atropine market growth during the next few years. Also, growing focus on funding for myopia research studies and increase in partnership by market vendors will lead to sizable demand in the market.
The report on the low-concentration atropine market covers the following areas:
Low-concentration atropine market sizing
Low-concentration atropine market forecast
Low-concentration atropine market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading low-concentration atropine market vendors that include AdvaCare Pharma, Aurolab, Bausch Lomb Corp., ENTOD INTERNATIONAL, Eyenovia Inc., Gmt Pharma, Grevis Pharmaceuticals Pvt. Ltd., ISKON REMEDIES and GMT, Jawa Pharmaceuticals India Pvt. Ltd., Medizia Biotech, OSRX Inc., Raymed Pharmaceutical Ltd., Santen Pharmaceutical Co. Ltd., Sydnexis Inc., Tache Pharmacy, Taiwan Biotech Co.,Ltd, Vyluma, and Aspire Pharma Ltd. Also, the low-concentration atropine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
- 1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market by Geography
- Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
- Exhibit 07: Executive Summary - Chart on Incremental Growth
- Exhibit 08: Executive Summary - Data Table on Incremental Growth
- Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
- 2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
- 3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- 4 Historic Market Size
- 4.1 Global low-concentration atropine market 2018 - 2022
- Exhibit 18: Historic Market Size - Data Table on global low-concentration atropine market 2018 - 2022 ($ million)
- 4.2 Type Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
- 4.3 Application Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
- 4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
- 5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
- 6 Market Segmentation by Type
- 6.1 Market segments
- Exhibit 30: Chart on Type - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
- 6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type
- 6.3 Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028
- Exhibit 34: Chart on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
- 6.4 Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028
- Exhibit 38: Chart on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
- 6.5 Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028
- Exhibit 42: Chart on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibit 43: Data Table on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibit 44: Chart on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
- 6.6 Market opportunity by Type
- Exhibit 46: Market opportunity by Type ($ million)
- Exhibit 47: Data Table on Market opportunity by Type ($ million)
- 7 Market Segmentation by Application
- 7.1 Market segments
- Exhibit 48: Chart on Application - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Application - Market share 2023-2028 (%)
- 7.2 Comparison by Application
- Exhibit 50: Chart on Comparison by Application
- Exhibit 51: Data Table on Comparison by Application
- 7.3 Child - Market size and forecast 2023-2028
- Exhibit 52: Chart on Child - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Child - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Child - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Child - Year-over-year growth 2023-2028 (%)
- 7.4 Adult - Market size and forecast 2023-2028
- Exhibit 56: Chart on Adult - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Adult - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Adult - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Adult - Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by Application
- Exhibit 60: Market opportunity by Application ($ million)
- Exhibit 61: Data Table on Market opportunity by Application ($ million)
- 8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2023-2028 (%)
- Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
- 9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison
- 9.3 Asia - Market size and forecast 2023-2028
- Exhibit 67: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.4 North America - Market size and forecast 2023-2028
- Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.5 Europe - Market size and forecast 2023-2028
- Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 China - Market size and forecast 2023-2028
- Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.9 Germany - Market size and forecast 2023-2028
- Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.10 Canada - Market size and forecast 2023-2028
- Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.11 Japan - Market size and forecast 2023-2028
- Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)
- 10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028
- 10.4 Market trends
- 11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 108: Impact of key risks on business
- 12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 109: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification
- 12.3 AdvaCare Pharma
- Exhibit 111: AdvaCare Pharma - Overview
- Exhibit 112: AdvaCare Pharma - Product / Service
- Exhibit 113: AdvaCare Pharma - Key offerings
- 12.4 Bausch Lomb Corp.
- Exhibit 114: Bausch Lomb Corp. - Overview
- Exhibit 115: Bausch Lomb Corp. - Business segments
- Exhibit 116: Bausch Lomb Corp. - Key news
- Exhibit 117: Bausch Lomb Corp. - Key offerings
- Exhibit 118: Bausch Lomb Corp. - Segment focus
- 12.5 ENTOD INTERNATIONAL
- Exhibit 119: ENTOD INTERNATIONAL - Overview
- Exhibit 120: ENTOD INTERNATIONAL - Key offerings
- 12.6 Eyenovia Inc.
- Exhibit 121: Eyenovia Inc. - Overview
- Exhibit 122: Eyenovia Inc. - Key offerings
- 12.7 Gmt Pharma
- Exhibit 123: Gmt Pharma - Overview
- Exhibit 124: Gmt Pharma - Product / Service
- Exhibit 125: Gmt Pharma - Key offerings
- 12.8 ISKON REMEDIES and GMT
- Exhibit 126: ISKON REMEDIES and GMT - Overview
- Exhibit 127: ISKON REMEDIES and GMT - Product / Service
- Exhibit 128: ISKON REMEDIES and GMT - Key offerings
- 12.9 Jawa Pharmaceuticals INDIA Pvt. Ltd.
- Exhibit 129: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Overview
- Exhibit 130: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Product / Service
- Exhibit 131: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Key offerings
- 12.10 Medizia Biotech
- Exhibit 132: Medizia Biotech - Overview
- Exhibit 133: Medizia Biotech - Product / Service
- Exhibit 134: Medizia Biotech - Key offerings
- 12.11 OSRX Inc.
- Exhibit 135: OSRX Inc. - Overview
- Exhibit 136: OSRX Inc. - Product / Service
- Exhibit 137: OSRX Inc. - Key offerings
- 12.12 Raymed Pharmaceutical Ltd.
- Exhibit 138: Raymed Pharmaceutical Ltd. - Overview
- Exhibit 139: Raymed Pharmaceutical Ltd. - Product / Service
- Exhibit 140: Raymed Pharmaceutical Ltd. - Key offerings
- 12.13 Santen Pharmaceutical Co. Ltd.
- Exhibit 141: Santen Pharmaceutical Co. Ltd. - Overview
- Exhibit 142: Santen Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 143: Santen Pharmaceutical Co. Ltd. - Key offerings
- 12.14 Sydnexis Inc.
- Exhibit 144: Sydnexis Inc. - Overview
- Exhibit 145: Sydnexis Inc. - Product / Service
- Exhibit 146: Sydnexis Inc. - Key offerings
- 12.15 Tache Pharmacy
- Exhibit 147: Tache Pharmacy - Overview
- Exhibit 148: Tache Pharmacy - Product / Service
- Exhibit 149: Tache Pharmacy - Key offerings
- 12.16 Taiwan Biotech Co.,Ltd
- Exhibit 150: Taiwan Biotech Co.,Ltd - Overview
- Exhibit 151: Taiwan Biotech Co.,Ltd - Product / Service
- Exhibit 152: Taiwan Biotech Co.,Ltd - Key offerings
- 12.17 Vyluma
- Exhibit 153: Vyluma - Overview
- Exhibit 154: Vyluma - Product / Service
- Exhibit 155: Vyluma - Key offerings
- 13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 156: Inclusions checklist
- Exhibit 157: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 158: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 159: Research methodology
- Exhibit 160: Validation techniques employed for market sizing
- Exhibit 161: Information sources
- 13.5 List of abbreviations
- Exhibit 162: List of abbreviations
- Exhibits :
- Exhibits 1: Executive Summary - Chart on Market Overview
- Exhibits 2: Executive Summary - Data Table on Market Overview
- Exhibits 3: Executive Summary - Chart on Global Market Characteristics
- Exhibits 4: Executive Summary - Chart on Market by Geography
- Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
- Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
- Exhibits 7: Executive Summary - Chart on Incremental Growth
- Exhibits 8: Executive Summary - Data Table on Incremental Growth
- Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
- Exhibits 10: Parent market
- Exhibits 11: Market Characteristics
- Exhibits 12: Offerings of vendors included in the market definition
- Exhibits 13: Market segments
- Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits 18: Historic Market Size - Data Table on global low-concentration atropine market 2018 - 2022 ($ million)
- Exhibits 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
- Exhibits 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
- Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
- Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
- Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
- Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
- Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
- Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
- Exhibits 30: Chart on Type - Market share 2023-2028 (%)
- Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
- Exhibits 32: Chart on Comparison by Type
- Exhibits 33: Data Table on Comparison by Type
- Exhibits 34: Chart on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibits 35: Data Table on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibits 36: Chart on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
- Exhibits 37: Data Table on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
- Exhibits 38: Chart on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibits 39: Data Table on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibits 40: Chart on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
- Exhibits 41: Data Table on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
- Exhibits 42: Chart on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibits 43: Data Table on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
- Exhibits 44: Chart on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
- Exhibits 45: Data Table on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
- Exhibits 46: Market opportunity by Type ($ million)
- Exhibits 47: Data Table on Market opportunity by Type ($ million)
- Exhibits 48: Chart on Application - Market share 2023-2028 (%)
- Exhibits 49: Data Table on Application - Market share 2023-2028 (%)
- Exhibits 50: Chart on Comparison by Application
- Exhibits 51: Data Table on Comparison by Application
- Exhibits 52: Chart on Child - Market size and forecast 2023-2028 ($ million)
- Exhibits 53: Data Table on Child - Market size and forecast 2023-2028 ($ million)
- Exhibits 54: Chart on Child - Year-over-year growth 2023-2028 (%)
- Exhibits 55: Data Table on Child - Year-over-year growth 2023-2028 (%)
- Exhibits 56: Chart on Adult - Market size and forecast 2023-2028 ($ million)
- Exhibits 57: Data Table on Adult - Market size and forecast 2023-2028 ($ million)
- Exhibits 58: Chart on Adult - Year-over-year growth 2023-2028 (%)
- Exhibits 59: Data Table on Adult - Year-over-year growth 2023-2028 (%)
- Exhibits 60: Market opportunity by Application ($ million)
- Exhibits 61: Data Table on Market opportunity by Application ($ million)
- Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits 63: Chart on Market share by geography 2023-2028 (%)
- Exhibits 64: Data Table on Market share by geography 2023-2028 (%)
- Exhibits 65: Chart on Geographic comparison
- Exhibits 66: Data Table on Geographic comparison
- Exhibits 67: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits 68: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits 69: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits 70: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibits 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
- Exhibits 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits 83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibits 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibits 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibits 86: Data Table on US - Year-over-year growth 2023-2028 (%)
- Exhibits 87: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibits 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibits 89: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibits 90: Data Table on China - Year-over-year growth 2023-2028 (%)
- Exhibits 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibits 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibits 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibits 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibits 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibits 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
- Exhibits 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibits 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibits 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibits 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
- Exhibits 103: Market opportunity by geography ($ million)
- Exhibits 104: Data Tables on Market opportunity by geography ($ million)
- Exhibits 105: Impact of drivers and challenges in 2023 and 2028
- Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
- Exhibits 107: Overview on factors of disruption
- Exhibits 108: Impact of key risks on business
- Exhibits 109: Vendors covered
- Exhibits 110: Matrix on vendor position and classification
- Exhibits 111: AdvaCare Pharma - Overview
- Exhibits 112: AdvaCare Pharma - Product / Service
- Exhibits 113: AdvaCare Pharma - Key offerings
- Exhibits 114: Bausch Lomb Corp. - Overview
- Exhibits 115: Bausch Lomb Corp. - Business segments
- Exhibits 116: Bausch Lomb Corp. - Key news
- Exhibits 117: Bausch Lomb Corp. - Key offerings
- Exhibits 118: Bausch Lomb Corp. - Segment focus
- Exhibits 119: ENTOD INTERNATIONAL - Overview
- Exhibits 120: ENTOD INTERNATIONAL - Key offerings
- Exhibits 121: Eyenovia Inc. - Overview
- Exhibits 122: Eyenovia Inc. - Key offerings
- Exhibits 123: Gmt Pharma - Overview
- Exhibits 124: Gmt Pharma - Product / Service
- Exhibits 125: Gmt Pharma - Key offerings
- Exhibits 126: ISKON REMEDIES and GMT - Overview
- Exhibits 127: ISKON REMEDIES and GMT - Product / Service
- Exhibits 128: ISKON REMEDIES and GMT - Key offerings
- Exhibits 129: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Overview
- Exhibits 130: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Product / Service
- Exhibits 131: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Key offerings
- Exhibits 132: Medizia Biotech - Overview
- Exhibits 133: Medizia Biotech - Product / Service
- Exhibits 134: Medizia Biotech - Key offerings
- Exhibits 135: OSRX Inc. - Overview
- Exhibits 136: OSRX Inc. - Product / Service
- Exhibits 137: OSRX Inc. - Key offerings
- Exhibits 138: Raymed Pharmaceutical Ltd. - Overview
- Exhibits 139: Raymed Pharmaceutical Ltd. - Product / Service
- Exhibits 140: Raymed Pharmaceutical Ltd. - Key offerings
- Exhibits 141: Santen Pharmaceutical Co. Ltd. - Overview
- Exhibits 142: Santen Pharmaceutical Co. Ltd. - Product / Service
- Exhibits 143: Santen Pharmaceutical Co. Ltd. - Key offerings
- Exhibits 144: Sydnexis Inc. - Overview
- Exhibits 145: Sydnexis Inc. - Product / Service
- Exhibits 146: Sydnexis Inc. - Key offerings
- Exhibits 147: Tache Pharmacy - Overview
- Exhibits 148: Tache Pharmacy - Product / Service
- Exhibits 149: Tache Pharmacy - Key offerings
- Exhibits 150: Taiwan Biotech Co.,Ltd - Overview
- Exhibits 151: Taiwan Biotech Co.,Ltd - Product / Service
- Exhibits 152: Taiwan Biotech Co.,Ltd - Key offerings
- Exhibits 153: Vyluma - Overview
- Exhibits 154: Vyluma - Product / Service
- Exhibits 155: Vyluma - Key offerings
- Exhibits 156: Inclusions checklist
- Exhibits 157: Exclusions checklist
- Exhibits 158: Currency conversion rates for US$
- Exhibits 159: Research methodology
- Exhibits 160: Validation techniques employed for market sizing
- Exhibits 161: Information sources
- Exhibits 162: List of abbreviations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook